Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694

Sort by:

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021

US$ 2,000.00

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency - D...

November 2021 69 pages

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

US$ 3,500.00

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This...

November 2021 70 pages

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers - Drugs In Development, 2021, pr...

November 2021 77 pages

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis - Drugs In Developmen...

November 2021 143 pages

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclea...

November 2021 136 pages

Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provid...

November 2021 4131 pages

Radiodermatitis - Drugs in Development, 2021

US$ 2,000.00

Radiodermatitis - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Drugs In Development, 2021, provides an overv...

November 2021 73 pages

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene...

November 2021 113 pages

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021

US$ 3,500.00

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021 SUMMARY Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close...

November 2021 40 pages

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Drugs In Develo...

November 2021 138 pages

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Drugs In Develop...

November 2021 84 pages

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome - Drugs In Development, 20...

November 2021 274 pages

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Drugs In Development...

November 2021 2115 pages

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021

US$ 3,500.00

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Sodium And Ch...

November 2021 42 pages

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinas...

November 2021 63 pages

Usher Syndrome - Drugs in Development, 2021

US$ 2,000.00

Usher Syndrome - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome - Drugs In Development, 2021, provides an overvie...

November 2021 82 pages

Wilson Disease - Drugs in Development, 2021

US$ 2,000.00

Wilson Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Drugs In Development, 2021, provides an overvie...

November 2021 69 pages

Wounds (Dermatology) - Drugs in Development, 2021

US$ 2,500.00

Wounds (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Drugs In Development, 2021, provides an overview...

November 2021 274 pages

Leading Animal Health Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,850.00

This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for:Assessment of major U.S. and international trends with potentially significant impac...

November 2021 -

Leading Generic and Specialty Drug Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 9,500.00

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions an...

November 2021 -

Leading Pharmaceutical Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological...

November 2021 -

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

US$ 2,600.00

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor gro...

November 2021 40 pages

Research Report on China's Bicalutamide Market, 2021-2025

US$ 2,600.00

Prostate cancer is one of the common malignant tumors in men. With the development of economy, factors like increasing environmental pollution, changing lifestyle, and aging population has caused the...

November 2021 40 pages

Pharmaceutical Processing Seals Market by Material (Metals, PTFE, Nitrile Rubber, Silicone, EPDM, FKM, FFKM, UHMWPE, PU), Type (O-Ring Seals, Gaskets, Lip Seals, D Seals), Application (Manufacturing Equipment), and Region - Global Forecast to 2026

US$ 2,970.00

... the pharmaceutical processing seals market. “O-rings accounted for the largest market share in pharmaceutical processing seals market.” O-rings accounted for the largest market share in the pharmaceutical processing seals market. O-rings are used in pharmaceutical equipment ...

November 2021 165 pages

U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End-use (Pharma, Biotech), And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 48 Business Hours U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Growth & Trends The U.K. biotechnology and pharmaceutical service...

November 2021 100 pages

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccines), Valence (Multivalent, Monovalent) - Global Forecast to 2028

US$ 4,175.00

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccin...

November 2021 229 pages

Antifungal Drugs: Technologies and Global Markets

US$ 5,500.00

This antifungal drugs report by BCC Research analyzes the global human antifungal market and assess its growth potential over the five-year period from 2016 to 2021.

November 2021 295 pages

Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report The active pharmaceutical ingredients market is expected to...

November 2021 284 pages

Global Trispecific Antibody Market Opportunity & Clinical Trials Insight 2028

US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global Trispecific Antibody Market Opportunity & Clinical Trials Insight 2028 Report Anal...

November 2021 97 pages

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026

US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight...

November 2021 222 pages

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute...

October 2021 2145 pages

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Drugs In Development...

October 2021 304 pages

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In D...

October 2021 97 pages

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spond...

October 2021 295 pages

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Drugs In De...

October 2021 305 pages

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperpla...

October 2021 109 pages

Cervical Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Cervical Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provid...

October 2021 2171 pages

Chondrosarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Chondrosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Drugs In Development, 2021, provides...

October 2021 727 pages

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia - Dr...

October 2021 1872 pages

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic...

October 2021 815 pages

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021

US$ 3,500.00

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Cyclin Depende...

October 2021 110 pages

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021,...

October 2021 137 pages

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Drugs In Devel...

October 2021 218 pages

Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy - Drugs In Develop...

October 2021 149 pages

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Devel...

October 2021 424 pages

Endometrial Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Endometrial Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2021,...

October 2021 2259 pages

Ewing Sarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Ewing Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Drugs In Development, 2021, provides a...

October 2021 938 pages

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021

US$ 3,500.00

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021 SUMMARY Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor o...

October 2021 65 pages

Gallbladder Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gallbladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Drugs In Development, 2021,...

October 2021 1118 pages

Gingivitis (Mouth and Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Gingivitis (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gingivitis - Drugs In Development, 2021...

October 2021 37 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

Discount Offer from GMD Research

Special Offer from MP Advisors

Special Offer on Therapy Class R...